Advancing IBD Research
Why T-Cell Transfer is the Gold Standard Pre-clinical drug development requires relevant and dependable models to benchmark the efficacy of therapeutic agents. Adoptive T...
Why T-Cell Transfer is the Gold Standard Pre-clinical drug development requires relevant and dependable models to benchmark the efficacy of therapeutic agents. Adoptive T...
Epistem is fully dedicated to using the latest cutting-edge methods to fast-track drug development for our biopharma partners. Our team is excited to connect...
Easily accessible good quality tissue is crucial for successful biomarker assays. The use of the plucked hair follicle as a surrogate tissue has gained...
The IHC Standard Over the last 20 years, antigen retrieval methods for immunohistochemistry (IHC) have improved and become increasingly standardised. Similarly, detection systems have...
Introduction In the ever-evolving field of biomedical research, the search for advanced models to study human physiology and disease has led to groundbreaking discoveries....
Targeted sequencing, also known as gene panel sequencing, utilises NGS sequencing technology to selectively sequence a subset of genes or regions within the genome....
May 14-16, 2023 • Convention Centre Dublin Spencer Dock North Wall Quay Dublin, Ireland We are thrilled to announce our attendance at BioEquity Europe...
Epistem’s team of experts will be exhibiting at Booth 3132! We will also present some of our preclinical work in IBD. If you would like...
AACR Annual Meeting 2023 Round-up! 16th to 19th April · Orange County Convention Center, Orlando Our Oncology Experts attended the AACR Annual Meeting 2023 to...
National DNA Day is a momentous occasion for the scientific community, celebrating advancements in genetic research and the discovery of the double helix structure...